You are viewing the site in preview mode
Skip to main content
| |
N = 655
|
|---|
|
Age (years), n (%)
|
|
18–29
|
81 (12)
|
|
30–39
|
185 (28)
|
|
40–49
|
207 (32)
|
|
50–59
|
147 (22)
|
|
≥ 60
|
35 (5)
|
|
Mean (SD)
|
43 (11)
|
|
Gender, n (%)
|
|
Male
|
462 (71)
|
|
Female
|
193 (29)
|
|
Highest educational level, n (%)
|
|
Not completed primary school
|
40 (6)
|
|
Completed primary school (9 years)
|
286 (44)
|
|
Completed high school (12 years)
|
260 (40)
|
|
≤ 3 years of college or university
|
57 (9)
|
|
> 3 years of college or university
|
12 (2)
|
|
Receiving OAT, n (%)
|
542 (83)
|
|
OAT opioid, n (%):
|
|
Methadone
|
212 (39)
|
|
Buprenorphinea
|
323 (60)
|
|
Long-acting morphine sulfate
|
7 (1)
|
|
Housing situation the past 30 days, n (%)
|
|
Owned or rented housing
|
518 (79)
|
|
Temporary residence (homeless shelter, with family or friends)
|
156 (24)
|
|
Living on street
|
27 (4)
|
|
Prison
|
7 (1)
|
|
Other
|
27 (4)
|
|
Ever injected substances, n (%)
|
573 (94)
|
|
Injected substances the past 30 days, n (%)
|
257 (42)
|
- OAT opioid agonist therapy, SD standard deviation
- a“Buprenorphine” includes buprenorphine, buprenorphine-naloxone, and buprenorphine depot
